Publications scientifiques

Idiopathic pulmonary fibrosis with benign SFTPC variant and pathogenic MARS1 mutations: can’t see the forest for the trees!

Auteurs : Castaldo A, Delestrain C, Diesler R, Merveilleux du Vignaux C, Onnee M, Touraine R, Chalabreysse L, Fanen P, Epaud R, Cottin V, De Becdelièvre A.

Sources : ERJ Open Res. 2023 Nov 6;9(6):00472-2023.

Sequential multimodal therapy in chronic thromboembolic pulmonary hypertension with mixed anatomical lesions: a proof of concept.

Auteurs : Jevnikar M, Solinas S, Brenot P, Lechartier B, Kularatne M, Montani D, Savale L, Garcia-Alonso C, Sitbon O, Beurnier A, Boucly A, Bulifon S, Seferian A, Roche A, Mercier O, Simonneau G, Fadel E, Humbert M, Jaïs X.

Sources : Eur Respir J. 2023 Nov 2;62(5):2300517.

Lack of Correlation of Sinonasal and Otologic Reported Symptoms With Objective Measurements Among Patients With Primary Ciliary Dyskinesia: An International Study.

Auteurs : Lam YT, Papon JF, Alexandru M, Anagiotos A, Armengot M, Boon M, Burgess A, Caversaccio N, Crowley S, Dheyauldeen SAD, Emiralioglu N, Erdem E, Gogh CV, Gokdemir Y, Gunaydın O, Haarman EG, Harris A, Hayn I, Ismail-Koch H, Karadag B, Kempeneers C, Kim S, Lorent N, Ozcelik U, Pioch C, Poirrier AM, Reula A, Roehmel J, Yiallouros P, Goutaki M.

Sources : Clin Exp Otorhinolaryngol. 2023 Nov;16(4):407-412.

Unclassifiable interstitial lung disease and autoimmunity: Towards IPAF in children?

Auteurs : Aoust L, Berteloot L, Drabent P, Garcelon N, Bodemer C, Molina TJ, Bader-Meunier B, Hadchouel A.

Sources : Pediatr Pulmonol. 2023 Nov;58(11):3303-3313.

Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome.

Auteurs : Berrada KR, Belot A, Neven B, Ohlmann C, Tronc F, Rice G, Thouvenin G, Dubus JC, Mazenq J, Frémond ML, Stremler N, Soummer-Feuillet S, Cottin V, Reix P.

Sources : J Clin Immunol. 2023 Nov;43(8):2156-2164.

Imaging Features of Autoimmune Disease-Related Interstitial Lung Diseases

Auteurs : Walsh SLF, Lafyatis RA, Cottin V.

Sources : J Thorac Imaging. 2023 Nov 1;38(Suppl 1):S30-S37.

Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.

Auteurs : Welch CL, Aldred MA, Balachandar S, Dooijes D, Eichstaedt CA, Gräf S, Houweling AC, Machado RD, Pandya D, Prapa M, Shaukat M, Southgate L, Tenorio-Castano J; ClinGen PH VCEP; Chung WK; International Consortium for Genetic Studies in Pulmonary Arterial Hypertension (PAH-ICON) at the Pulmonary Vascular Research Institute (PVRI).

Sources : Genet Med. 2023 Nov;25(11):100925.

Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension

Auteurs : Kularatne M, Boucly A, Savale L, Solinas S, Cheron C, Roche A, Jevnikar M, Jaïs X, Montani D, Humbert M, Sitbon O.

Sources : Expert Opin Pharmacother. 2023 Oct 23:1-15.

Lung transplantation as a rescue option in childhood critical pulmonary Langerhans cell histiocytosis.

Auteurs : Heritier S, Donadieu J, Leger PL, De Tersant M, Della Vallee V, Barkaoui MA, Le Louet S, Tazi A, Taytard J, Corvol H, Helias-Rodzevicz Z, Emile JF, Fadel E, Fabre D, Feuillet S, Nathan N.

Sources : Pediatr Pulmonol. 2023 Oct 4.

In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study.

Auteurs : Chaigne B, Chevalier K, Boucly A, Agard C, Baudet A, Bourdin A, Chabanne C, Cottin V, Fesler P, Goupil F, Jego P, Launay D, Lévesque H, Maurac A, Mohamed S, Tromeur C, Rottat L, Sitbon O, Humbert M, Mouthon L.

Sources : Rheumatology (Oxford). 2023 Oct 3;62(10):3261-3267.